Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS)
CNY 6.93
(0.14%)
CNY 6.93
(0.14%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 84.32 Million CNY | 42.68% |
| 2022 | 59.1 Million CNY | -2.83% |
| 2021 | 60.82 Million CNY | 7.58% |
| 2020 | 56.53 Million CNY | -34.51% |
| 2019 | 86.32 Million CNY | -5.31% |
| 2018 | 91.16 Million CNY | -9.24% |
| 2017 | 100.44 Million CNY | 59.65% |
| 2016 | 62.91 Million CNY | 40.15% |
| 2015 | 44.89 Million CNY | 18.36% |
| 2014 | 37.92 Million CNY | 31.09% |
| 2013 | 28.93 Million CNY | -14.77% |
| 2012 | 33.94 Million CNY | 3.61% |
| 2011 | 32.76 Million CNY | -4.4% |
| 2010 | 34.27 Million CNY | 40.43% |
| 2009 | 24.4 Million CNY | -3.79% |
| 2008 | 25.36 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 83.41 Million CNY | -3.32% |
| 2024 Q1 | 78.81 Million CNY | -6.53% |
| 2024 Q2 | 86.28 Million CNY | 9.47% |
| 2023 Q1 | 77.51 Million CNY | 31.15% |
| 2023 Q4 | 84.32 Million CNY | -8.83% |
| 2023 FY | 84.32 Million CNY | 42.68% |
| 2023 Q3 | 92.49 Million CNY | 1.93% |
| 2023 Q2 | 90.74 Million CNY | 17.07% |
| 2022 Q4 | 59.1 Million CNY | -1.06% |
| 2022 Q3 | 59.73 Million CNY | 2.79% |
| 2022 Q2 | 58.11 Million CNY | -4.58% |
| 2022 Q1 | 60.9 Million CNY | 0.14% |
| 2022 FY | 59.1 Million CNY | -2.83% |
| 2021 Q4 | 60.82 Million CNY | 25.79% |
| 2021 Q1 | 65.96 Million CNY | 16.68% |
| 2021 FY | 60.82 Million CNY | 7.58% |
| 2021 Q2 | 40.96 Million CNY | -37.9% |
| 2021 Q3 | 48.35 Million CNY | 18.05% |
| 2020 Q3 | 70.55 Million CNY | -21.44% |
| 2020 Q1 | 92.31 Million CNY | 6.94% |
| 2020 FY | 56.53 Million CNY | -34.51% |
| 2020 Q4 | 56.53 Million CNY | -19.87% |
| 2020 Q2 | 89.81 Million CNY | -2.71% |
| 2019 Q2 | 92.74 Million CNY | 13.22% |
| 2019 Q4 | 86.32 Million CNY | -18.33% |
| 2019 FY | 86.32 Million CNY | -5.31% |
| 2019 Q1 | 81.92 Million CNY | -10.14% |
| 2019 Q3 | 105.69 Million CNY | 13.96% |
| 2018 Q2 | 119.41 Million CNY | 14.09% |
| 2018 Q4 | 91.16 Million CNY | -21.09% |
| 2018 Q3 | 115.53 Million CNY | -3.25% |
| 2018 FY | 91.16 Million CNY | -9.24% |
| 2018 Q1 | 104.66 Million CNY | 4.2% |
| 2017 Q3 | 93.4 Million CNY | 2.69% |
| 2017 FY | 100.44 Million CNY | 59.65% |
| 2017 Q4 | 100.44 Million CNY | 7.54% |
| 2017 Q2 | 90.95 Million CNY | 23.66% |
| 2017 Q1 | 73.55 Million CNY | 16.91% |
| 2016 Q1 | 49.26 Million CNY | 9.73% |
| 2016 Q2 | 60.02 Million CNY | 21.86% |
| 2016 Q4 | 62.91 Million CNY | 11.85% |
| 2016 Q3 | 56.25 Million CNY | -6.29% |
| 2016 FY | 62.91 Million CNY | 40.15% |
| 2015 Q2 | 42.13 Million CNY | 14.73% |
| 2015 Q1 | 36.72 Million CNY | -3.17% |
| 2015 FY | 44.89 Million CNY | 18.36% |
| 2015 Q4 | 44.89 Million CNY | -1.25% |
| 2015 Q3 | 45.45 Million CNY | 7.89% |
| 2014 Q2 | 29.51 Million CNY | 24.88% |
| 2014 Q1 | 23.63 Million CNY | -18.31% |
| 2014 FY | 37.92 Million CNY | 31.09% |
| 2014 Q4 | 37.92 Million CNY | 7.12% |
| 2014 Q3 | 35.4 Million CNY | 19.96% |
| 2013 Q4 | 28.93 Million CNY | 0.0% |
| 2013 FY | 28.93 Million CNY | -14.77% |
| 2013 Q1 | - CNY | 0.0% |
| 2012 FY | 33.94 Million CNY | 3.61% |
| 2011 Q3 | 34.58 Million CNY | 0.0% |
| 2011 FY | 32.76 Million CNY | -4.4% |
| 2011 Q4 | 32.76 Million CNY | -5.26% |
| 2010 FY | 34.27 Million CNY | 40.43% |
| 2009 FY | 24.4 Million CNY | -3.79% |
| 2008 FY | 25.36 Million CNY | 0.0% |